Variables
RMP-R
RMP-S
Total
COR (95%CI)
AOR (95%CI)
Sex
Male
57 (44.1)
72 (55.8)
129 (59.4)
1.9 (1.1-3.3)
2.2 (1.2-3.9)
Female
53 (60.2)
35 (39.8)
88 (40.6)
Age
≥ 51
9 (36)
16 (64)
25 (11.5)
1
1
41-50
13 (39.4)
20 (60.6)
33 (15.2)
1.2 (0.4-3.2)
0.8 (0.3-2.6)
31-40
25 (54.3)
21 (45.7)
46 (21.2)
2.1 (0.78-5.8)
0.4 (0.2-1.2)
21-30
47 (58)
34 (42)
81 (37.3)
2.5 (1.0‑6.2)
0.4 (0.2-1.1)
Nov-20
16 (51.6)
15 (48.4)
31 (14.3)
1.9 (0.7-5.6)
0.5 (0.2-1.7)
02-Oct
0 (0)
1 (100)
1 (0.5)
-
-
HIV status
Negative
65 (53.3)
57 (46.7)
122 (56.2)
1
1
Positive
18 (54.5)
15 (45.5)
33 (15.2)
1 (0.5-2.3)
1 (0.5-2.4)
Unknown
27 (43.5)
35 (56.5)
62 (28.6)
0.7 (0.4-1.3)
1.7 (0.8-3.4)
Treatment history
New
13 (41.9)
18 (58.1)
31 (14.3)
1.5 (0.7-3.3)
0.4 (0.03-5.6)
Retreatment
97 (52.2)
89 (47.8)
186 (85.7)
TB history
New
15 (44.1)
19 (55.9)
34 (15.7)
1
1
Relapse
40 (47.6)
44 (52.4)
84 (38.7)
1.2 (.5-2.6)
2 (0.04-91)
Failure
46 (51.1)
34 (37.8)
80 (36.9)
1.7 (0.8-3.9)
2.2 (0.2-30)
Defaulter
2 (28.6)
5 (71.4)
7 (3.22)
0.5 (0.1-3.0)
1.2 (0.9-17)
Other
0 (0)
2 (100)
2 (0.9)
-
3 (0.14-69)
Unknown
7 (70)
3 (30)
10 (4.6)
3 (0.7-13.4)
-
Total
110 (50.7)
107(49.3)
217 (100)
Table 4:
Logistic regression analysis showing the associated factors with MDR-TB and/or RMP-MR with socio demographic and clinical history among TB positive, presumptive MDR-TB cases, ANRS, 2013
